A Q3 2018 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q3 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.2B+8.0% YoY

Gross Profit

$661M54.9% margin

Operating Income

$216M18.0% margin

Net Income

$236M19.6% margin

EPS (Diluted)

$0.73

QoQ Revenue Growth

-0.2%

Cash Flow

Operating Cash Flow

$197M

Free Cash Flow

$164M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$8.3B

Total Liabilities

$3.8B

Stockholders' Equity

$4.6B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+8.0%
Gross Profit	$661M	$596M	+10.9%
Operating Income	$216M	$201M	+7.5%
Net Income	$236M	$175M	+34.9%

Revenue Segments

Life Sciences and Applied Markets

$540M45%

Agilent CrossLab

$426M35%

Diagnostics and Genomics

$237M20%